title: Consensus recommendations for treatment for dogs with serology positive glomerular disease.
authors.forename: R E
authors.initials: RE
authors.lastname: Goldstein
authors.forename: C
authors.initials: C
authors.lastname: Brovida
authors.forename: M J
authors.initials: MJ
authors.lastname: Fernández-Del Palacio
authors.forename: M P
authors.initials: MP
authors.lastname: Littman
authors.forename: D J
authors.initials: DJ
authors.lastname: Polzin
authors.forename: A
authors.initials: A
authors.lastname: Zatelli
authors.forename: L D
authors.initials: LD
authors.lastname: Cowgill
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D025065:Borrelia burgdorferi / Q000276:immunology / Q000302:isolation & purification*; D004283:Dog Diseases / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology*; D004285:Dogs; D005921:Glomerulonephritis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology / Q000662:veterinary*; D008193:Lyme Disease / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology / Q000662:veterinary*
chemical_list: D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents
keywords: Borrelia burgdorferi; Formal consensus; Leishmania; Lyme